A Prospective, Randomized, Open Label Study To Evaluate The Safety And Efficacy Of Mulmina Mango Ready To Drink as A Supplement In Children With Respiratory Tract Infections

Jagdale industries pvt Ltd0 个研究点目标入组 125 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•i.Volunteer aged between 7-14 years (both inclusive)
•ii.Proven to be healthy and parents willing to give written consent to participate

•i.Children having cerebral palsy physical disability and children requiring IEP with epilepsy will be excluded from the study
•ii.Patients with preexisting severe systemic disease necessitating long term medication.
•iii.Evidence of significant uncontrolled comorbid disease which in the investigators opinion would jeopardize patient participation.
•iv.Any onco neurological congenital or acquired vascular or systemic disorder which could affect any of the efficacy assessments.
•v.Participation in the current or previous treatment with any approved or investigational health supplements during the past 1 month.

发起方